151. Diagnostic ability of a 22G Franseen needle in endoscopic ultrasound‑guided fine needle aspiration of subepithelial lesions
- Author
-
Ryuichiro Araki, Masanori Kobayashi, Akashi Fujita, Tsutomu Kobatake, Koji Nagata, Kazuhiro Minami, Yuki Tanisaka, Masafumi Mizuide, and Shomei Ryozawa
- Subjects
Endoscopic ultrasound ,Cancer Research ,medicine.diagnostic_test ,business.industry ,Histology ,Articles ,Endoscopic ultrasonography ,03 medical and health sciences ,0302 clinical medicine ,Fine-needle aspiration ,Oncology ,030220 oncology & carcinogenesis ,medicine ,030211 gastroenterology & hepatology ,business ,Nuclear medicine - Abstract
The differential diagnosis of gastrointestinal subepithelial lesions (SELs) such as gastrointestinal stromal tumors from other benign tumors is important. In the present study, adequate sample rates of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) with a 22G Franseen needle for SELs were evaluated. The present study included 57 consecutive lesions (61 sessions) of EUS-FNA using a 22G needle to evaluate SELs between July 2013 and October 2017. Adequate sample rates were compared retrospectively between a 22G conventional needle group (C group) and a 22G Franseen needle group (F group). The overall adequate sample rate was 80.3%. The adequate sample rates in the C and F groups were 75.0% (33/44) and 94.1% (16/17), respectively (P=0.15). For lesions ≥20 mm, the adequate sample rates were 82.8% (24/29) in the C group and 91.7% (11/12) in the F group, 8.9% higher in the F group. However, for lesions
- Published
- 2018
- Full Text
- View/download PDF